Home

JOAN P NEUSCHELER

CIK 1275802 · last filed 2008-01-30

JOAN P NEUSCHELER is a corporate insider who has filed 18 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider disposed of $220.5K of ARXT on Jan 30, 2008. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. 3 SEC filings were submitted jointly with Timothy Buono.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

18

Lifetime Open-Market Net

-$1.50M

Filer Profile

Reported Address
C/O ESSENTIAL GROUP, INC.
1325 TRI-STATE PKWY, SUITE 300
GURNEE, IL 60031
Phone
(847) 855-7500
Related Filers
Timothy Buono — 3 joint filings, latest 2008-02-29
Lyle Hohnke — 3 joint filings, latest 2008-02-29
TULLIS DICKERSON CAPITAL FOCUS III, L.P. — 3 joint filings, latest 2008-02-29
JAMES L L TULLIS — 3 joint filings, latest 2008-02-29
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Director 0 — — -$1.50M 18 2008-01-30

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2008-01-30 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Disp (D) −3,675 -$220.5K EDGAR
2008-01-25 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted U −194,965 -$11.70M EDGAR
2008-01-18 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Other (J) −239,823 $0 EDGAR
2008-01-03 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Grant (A) +210 $0 EDGAR
2007-12-18 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Grant (A) — $0 EDGAR
2007-12-12 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Sell (S) −2,000 -$118.4K EDGAR
2007-11-13 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Sell (S) −2,000 -$90.0K EDGAR
2007-10-03 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Grant (A) +323 $0 EDGAR
2007-08-09 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Sell (S) −2,000 -$88.0K EDGAR
2007-07-30 Adams Respiratory Therapeutics, Inc. (ARXT) Delisted Sell (S) −23,880 -$985.8K EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.